Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jul 24, 2026
Reporting period
Not applicable
Filed with the SEC
Jul 28, 2026
CFOGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001724169-26-000035
Filed / recorded
Jul 28, 2026, 9:34 PM UTC
Added to OQRO
Oct 6, 2026, 7:37 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Elanco Animal Health Inc
Issuer CIK
1739104
Ticker
ELAN
Reporting person
Robert M Vanhimbergen
Relationship
Officer
Officer title
EVP and CFO
Security
Deferred Stock Units
Table
Derivative (Table II)
Transaction date
Jul 24, 2026
Transaction code
A
Shares / units
7.9093
Price per share
$24.91
Acquired / disposed
Acquired (A)
Shares owned after
124.6979
Ownership form
Direct
Amendment
No
Footnotes from the filing
Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.